Total Payments
$15,711
2024 Payments
$1,000
Companies
5
Transactions
18
Medicare Patients
995
Medicare Billing
$116,179
Payment Breakdown by Category
Other$11,425 (72.7%)
Consulting$2,650 (16.9%)
Travel$990.36 (6.3%)
Food & Beverage$590.68 (3.8%)
Education$55.09 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,425 | 4 | 72.7% |
| Consulting Fee | $2,650 | 2 | 16.9% |
| Travel and Lodging | $990.36 | 5 | 6.3% |
| Food and Beverage | $590.68 | 3 | 3.8% |
| Education | $55.09 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ModernaTX, Inc. | $7,800 | 2 | $0 (2023) |
| PFIZER INC. | $3,923 | 8 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $2,789 | 6 | $0 (2021) |
| Shionogi Inc | $1,170 | 1 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $28.48 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,000 | 1 | PFIZER INC. ($1,000) |
| 2023 | $9,413 | 4 | ModernaTX, Inc. ($7,800) |
| 2021 | $1,209 | 3 | Shionogi Inc ($1,170) |
| 2020 | $12.70 | 1 | Merck Sharp & Dohme Corporation ($12.70) |
| 2017 | $4,076 | 9 | Merck Sharp & Dohme Corporation ($2,766) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | PFIZER INC. | COMIRNATY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: VACCINES | ||||||
| 12/04/2023 | PFIZER INC. | PAXLOVID (Drug) | Consulting Fee | Cash or cash equivalent | $1,480.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/13/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $133.35 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/12/2023 | ModernaTX, Inc. | Moderna Covid-19 Vaccine (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/12/2023 | ModernaTX, Inc. | Moderna Covid-19 Vaccine (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/14/2021 | Janssen Pharmaceuticals, Inc | — | Education | In-kind items and services | $28.48 | General |
| 11/19/2021 | Merck Sharp & Dohme Corporation | PREVYMIS (Drug) | Education | In-kind items and services | $10.87 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/31/2021 | Shionogi Inc | Fetroja (Drug) | Consulting Fee | Cash or cash equivalent | $1,170.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 03/04/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Education | In-kind items and services | $12.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/13/2017 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug) | Education | In-kind items and services | $3.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/27/2017 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/27/2017 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/23/2017 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $112.60 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/27/2017 | PFIZER INC. | PREVNAR - 13 (Biological) | Travel and Lodging | In-kind items and services | $55.00 | General |
| Category: VACCINES | ||||||
| 01/19/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $393.10 | General |
| 01/19/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $372.08 | General |
| 01/19/2017 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $344.73 | General |
| 01/19/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $145.18 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 278 | 453 | $189,620 | $32,598 |
| 2022 | 9 | 272 | 395 | $167,539 | $31,303 |
| 2021 | 10 | 293 | 458 | $182,134 | $37,957 |
| 2020 | 5 | 152 | 209 | $74,793 | $14,322 |
Total Patients
995
Total Services
1,515
Medicare Billing
$116,179
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 106 | 197 | $98,894 | $15,224 | 15.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 107 | $29,962 | $7,046 | 23.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 30 | $16,240 | $3,241 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 48 | 60 | $21,240 | $3,076 | 14.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 21 | 21 | $13,566 | $2,102 | 15.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 24 | $3,642 | $984.00 | 27.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 14 | 14 | $6,076 | $924.69 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 86 | 145 | $70,774 | $11,097 | 15.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 76 | $17,552 | $4,430 | 25.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 45 | $17,120 | $3,764 | 22.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 18 | $11,636 | $2,956 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 45 | 49 | $16,955 | $2,537 | 15.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 17 | 20 | $13,402 | $2,295 | 17.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 15 | 15 | $9,349 | $1,674 | 17.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $5,260 | $1,326 | 25.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 15 | 15 | $5,491 | $1,223 | 22.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 79 | 150 | $64,050 | $11,780 | 18.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 31 | 79 | $27,273 | $6,788 | 24.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 31 | 43 | $24,845 | $4,880 | 19.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 32 | 59 | $13,393 | $3,526 | 26.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 17 | $10,778 | $2,831 | 26.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 39 | 45 | $13,218 | $2,140 | 16.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $7,758 | $2,032 | 26.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 18 | 18 | $6,154 | $1,501 | 24.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 14 | 14 | $8,530 | $1,501 | 17.6% |
About Dr. Stuart Cohen, M.D
Dr. Stuart Cohen, M.D is a Infectious Disease healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043290455.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Cohen, M.D has received a total of $15,711 in payments from pharmaceutical and medical device companies, with $1,000 received in 2024. These payments were reported across 18 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,425).
As a Medicare-enrolled provider, Cohen has provided services to 995 Medicare beneficiaries, totaling 1,515 services with total Medicare billing of $116,179. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Sacramento, CA
- Active Since 01/20/2006
- Last Updated 05/02/2008
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043290455
Products in Payments
- Moderna Covid-19 Vaccine (Biological) $7,800
- ZEPATIER (Drug) $2,763
- PAXLOVID (Drug) $1,613
- Fetroja (Drug) $1,170
- COMIRNATY (Biological) $1,000
- PREVNAR - 13 (Biological) $55.00
- ZERBAXA (Drug) $12.70
- PREVYMIS (Drug) $10.87
- ISENTRESS (Drug) $3.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Sacramento
Claire Pomeroy, M.d., M.b.a, M.D., M.B.A
Infectious Disease — Payments: $2.5M
Infectious Disease $2.5M
Dr. David Asmuth, M.d, M.D
Infectious Disease — Payments: $424,974
Infectious Disease $424,974
Daniel Ikeda, M.d, M.D
Infectious Disease — Payments: $8,220
Infectious Disease $8,220
Dr. Richard Pollard, Md, MD
Infectious Disease — Payments: $4,763
Infectious Disease $4,763
Vinod Trivedi, Md, MD
Infectious Disease — Payments: $4,508
Infectious Disease $4,508
Dr. Brett Laurence, Md, MD
Infectious Disease — Payments: $3,565
Infectious Disease $3,565